1999•Emerging DrugsRequires access
Tumour necrosis factor antagonists
David Chantry
Open publisher page 4 citations
Abstract
No abstract.
David Chantry
Abstract
No abstract.
OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
No abstract.
Key concepts: Necrosis, Tumor necrosis factor alpha, Medicine, Immunology, Internal medicine